Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.4.0.3
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 3,436 $ 1,760
Premium and related receivables 2,529 1,279
Short term investments 269 176
Other current assets 1,317 390
Total current assets 7,551 3,605
Long term investments 3,973 1,927
Restricted deposits 143 115
Property, software and equipment, net 580 518
Goodwill 4,442 842
Intangible assets, net 1,646 155
Other long term assets 317 177
Total assets 18,652 7,339
Current liabilities:    
Medical claims liability 3,863 2,298
Accounts payable and accrued expenses 3,228 976
Return of premium payable 579 207
Unearned revenue 197 143
Current portion of long term debt 4 5
Total current liabilities 7,871 3,629
Long term debt 4,276 1,216
Other long term liabilities 1,052 170
Total liabilities $ 13,199 $ 5,015
Commitments and contingencies
Redeemable noncontrolling interests $ 144 $ 156
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at March 31, 2016 and December 31, 2015 0 0
Common stock, $0.001 par value; authorized 400,000,000 shares; 175,952,159 issued and 170,449,444 outstanding at March 31, 2016, and 126,855,477 issued and 120,342,981 outstanding at December 31, 2015 0 0
Additional paid-in capital 4,084 956
Accumulated other comprehensive earnings (loss) 10 (10)
Retained earnings 1,341 1,358
Treasury stock, at cost (5,502,715 and 6,512,496 shares, respectively) (138) (147)
Total Centene stockholders’ equity 5,297 2,157
Noncontrolling interest 12 11
Total stockholders’ equity 5,309 2,168
Total liabilities and stockholders’ equity $ 18,652 $ 7,339